A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care

Top Antivir Med. 2017 Dec/Jan;24(4):142-151.

Abstract

The IAS-USA volunteer Board of Directors met in October 2016 for its annual meeting. For the second year, the Board conducted a live, hour-long, interactive, roundtable webinar covering current questions and issues in HIV research, prevention, and care. Important highlights from the Board's discussion, which was moderated by Paul A. Volberding, MD, are included below. Members of the IAS-USA volunteer Board of Directors are Constance A. Benson, MD; Judith S. Currier, MD; Carlos del Rio, MD; Joel E. Gallant, MD, MPH; Roy M. Gulick, MD, MPH; Jeanne M. Marrazzo, MD, MPH; Douglas D. Richman, MD; Michael S. Saag, MD; Robert T. Schooley, MD; and Paul A. Volberding, MD.

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active / methods*
  • Biomedical Research / trends
  • Drug Discovery / trends
  • HIV Infections / drug therapy*
  • HIV Infections / prevention & control*
  • Humans
  • Societies, Scientific
  • United States

Substances

  • Anti-HIV Agents